Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound preparation for treating acute glomerulitis

A technology for glomerulitis and compound preparations, which can be applied to medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., can solve the problems of high cost, large side effects, etc. toxic side effects

Inactive Publication Date: 2017-05-24
ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the effective treatment of acute glomerulonephritis is mainly through Western medicine, but Western medicine usually has high costs and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A compound preparation for treating acute glomerulitis, the main raw materials in parts by weight are: 8 parts of raw astragalus, 2 parts of ephedra, 7 parts of carpinine of rutaecarpa, 15 parts of suberone, 12 parts of thiocolchicoside, 7 parts of - 4 parts of ethylcamptothecin, 4 parts of menthol, 26 parts of limonin, 7 parts of indica dalbalin, 2 parts of alisitol A-24-acetate.

[0016] A preparation method for a compound preparation for treating acute glomerulitis, the specific steps are:

[0017] First, in a pharmaceutical-grade clean area, raw astragalus, ephedra, evodia carpine, suberone, thiocolchicoside, 7-ethylcamptothecin, menthol, limonin, Indian Dalberghin and alisitol A-24-acetate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD≤5%, pressed into tablets after mixing and dried at low temperature, temperature The compound preparation for treating acute glomerulitis is obtained after being p...

Embodiment 2

[0019] A compound preparation for treating acute glomerulitis, the main raw materials in parts by weight are: 11 parts of raw astragalus, 2 parts of ephedra, 8 parts of carpinine of rutaecarpa, 17 parts of suberone, 14 parts of thiocolchicoside, 7 parts of - 4 parts of ethylcamptothecin, 4 parts of menthol, 26 parts of limonin, 7 parts of indica dalbalin, 2 parts of alisitol A-24-acetate.

[0020] A preparation method for a compound preparation for treating acute glomerulitis, the specific steps are:

[0021] First, in a pharmaceutical-grade clean area, raw astragalus, ephedra, evodia carpine, suberone, thiocolchicoside, 7-ethylcamptothecin, menthol, limonin, Indian Dalberghin and alisitol A-24-acetate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD≤5%, pressed into tablets after mixing and dried at low temperature, temperature The compound preparation for treating acute glomerulitis is obtained after being ...

Embodiment 3

[0023] A compound preparation for treating acute glomerulitis, the main raw materials in parts by weight are: 15 parts of raw astragalus, 4 parts of ephedra, 9 parts of carpineine evodia, 19 parts of suberone, 15 parts of thiocolchicoside, 7 parts - 5 parts of ethylcamptothecin, 6 parts of menthol, 27 parts of limonin, 10 parts of indica, 3 parts of alisitol A-24-acetate.

[0024] A preparation method for a compound preparation for treating acute glomerulitis, the specific steps are:

[0025] First, in a pharmaceutical-grade clean area, raw astragalus, ephedra, evodia carpine, suberone, thiocolchicoside, 7-ethylcamptothecin, menthol, limonin, Indian Dalbergin and alisitol A-24-acetate, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD≤5%, pressed into tablets after mixing and dried at low temperature, temperature The temperature is controlled at 6°C, and the compound preparation for treating acute glomerul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound preparation for treating acute glomerulitis. The compound preparation for treating acute glomerulitis mainly comprises the following raw materials in parts by weight: 8-22 parts of raw radix astragalis, 2-6 parts of herba ephedra, 7-11 parts of evocarpine, 15-20 parts of friedelin, 12-18 parts of thiocolchicoside, 4-6 parts of 7-ethylcamptothecin, 4-8 parts of menthol, 26-28 parts of limonin, 7-12 parts of sissotrin and 2-4 parts of alisol A-24-acetate. In the medicine disclosed by the invention, the ingredients are strictly chosen according to the known mechanism of acute glomerulitis so as to achieve an aim of comprehensive rehabilitation; and the medicine has the characteristics of fast effect, stable action, convenience in carrying and taking and no toxic or side effect caused by long-term administration.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a compound preparation for treating acute glomerulitis. Background technique [0002] Acute glomerulonephritis (acute glomerulonephritis) is often referred to as acute nephritis. Acute nephritis is a disease mainly caused by diffuse glomerular damage in both kidneys caused by allergic reaction after infection. In a broad sense, it refers to a group of glomerular diseases with different etiologies and pathogenesis, but clinically manifested as acute onset, characterized by hematuria, proteinuria, edema, hypertension, and decreased glomerular filtration rate. Often called acute nephritic syndrome. Clinically, the vast majority belong to acute post-streptococcal glomerulonephritis. The disease can occur at any age, and is more common in children. It is more common in the age of 3 to 8 years old, and rare in the age below 2 years old. The ratio of male to female is about 2:1....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/481A61P13/12A61K31/47A61K31/704A61K31/4745A61K31/045A61K31/585A61K31/56A61K31/7048A61K31/567
CPCA61K36/481A61K31/045A61K31/47A61K31/4745A61K31/56A61K31/567A61K31/585A61K31/704A61K31/7048A61K36/17
Inventor 不公告发明人
Owner ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com